← Evidence map

TrialNeuro-oncology2014

Phase II trial of 7 days on/7 days off temozolmide for recurrent high-grade glioma.

Seunggu J Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

32 papers cite it

2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
this paperpooled ittrialcites it

The trial

NCT00619112phase 260 enrolled2007
Full record →Abstract, authors, funding and every citing paper · PMID 24670608